Litcius/Paper detail

Development of isoselenazolium chlorides as selective pyruvate kinase isoform M2 inhibitors

Pāvels Dimitrijevs, Marina Makrecka‐Kuka, Agnieszka Bogucka, Marko Hyvönen, Teodors Panteļejevs, Pavel Arsenyan

2023European Journal of Medicinal Chemistry14 citationsDOIOpen Access PDF

Topics & Concepts

PKM2ChemistryPyruvate kinaseMechanism of actionCancer cellKinaseGlycolysisGene isoformBiochemistryOxidative phosphorylationCancerEnzymeIn vitroBiologyGeneGeneticsMitochondrial Function and PathologyCancer, Hypoxia, and MetabolismATP Synthase and ATPases Research
Development of isoselenazolium chlorides as selective pyruvate kinase isoform M2 inhibitors | Litcius